Tasadenoturev
N/A
Report date: 2026/05/16 20:00:17
Base Information
Drug NameTasadenoturev
Drug Alias Name +[12]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[15]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDnatrix IncThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A
Develop Information
Active CompaniesDnatrix IncThe University Of Texas MD Anderson Cancer CenterUniversity Of Navarra +[4]
Inactive CompaniesUniversity Of Alabama At Birmingham
Active Indications +[11]
Inactive Indications +[4]
Other Information
ATC CodeN/A
Related LinksN/A